by PantheonAdmin | Nov 17, 2023
by PantheonAdmin | Nov 15, 2023
Becky Pferdehirt is an investing partner on the a16z Bio + Health team. Prior to joining Andreessen Horowitz, Becky worked at Amgen where she most recently led business development efforts for therapeutic platform partnerships. Before moving to BD Becky was a research...
by PantheonAdmin | Nov 15, 2023
Jorge Conde is a General Partner on the Bio + Health team at Andreessen Horowitz, where he focuses on life sciences and healthcare investments across therapeutics, diagnostics, tools, and software. Jorge currently serves on the boards of Asimov, CAMP4, Cartography,...
by PantheonAdmin | Nov 15, 2023
Seth focuses on 8VC’s Bio-IT investment area where he invests, builds and supports companies across areas such as therapeutics, tools, bio-infrastructures and broader applications of biology. He joined 8VC from Amgen’s Business Development technology group,...
by PantheonAdmin | May 31, 2023
Janine Schuurman, Ph.D. is an expert in antibody biology and translational research with a demonstrated history of working in drug discovery and development. Dr. Schuurman is a thought leader and an active Board Member of The Antibody Society, an international,...
